| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $163,112,209 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK113625 | Contributions of Hepatic and Intestinal Pathways to Cholesterol Excretion | 002 | 8 | NIH | 4/15/2025 | $491,578 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K99AA031309 | Examining the Relationship Between Ongoing Alcohol Use, Suicidal Thoughts and Behaviors and Related Constructs, and Behavioral Economic Decision-Making | 000 | 2 | NIH | 8/27/2025 | $128,951 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R24OD010435 | Research Resources for Model Amphibians | 001 | 23 | NIH | 7/24/2025 | $101,507 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R24OD010435 | Research Resources for Model Amphibians | 000 | 23 | NIH | 2/14/2025 | $406,029 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA061996 | Optimizing PrEP Care Delivery through Adaptive Intervention Strategies for Underserved Rural People who Inject Drugs | 001 | 2 | NIH | 7/11/2025 | $618,753 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | ASTWH210102 | Violence Intervention and Prevention (VIP) Corps to Reduce Maternal Injuries and Deaths due to Violence | 00 | 5 | DHHS/OS | 9/27/2025 | $300,000 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R00DE031825 | The Role of SoxE Transcription Factors in Neural Crest Cell Specialization | 001 | 3 | NIH | 4/7/2025 | $249,000 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AI187757 | Protective roles of CD180 and NOD1 in the protective immunity against cerebral Toxoplasma infection | 001 | 1 | NIH | 9/12/2025 | -$423,500 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AI187757 | Protective roles of CD180 and NOD1 in the protective immunity against cerebral Toxoplasma infection | 000 | 1 | NIH | 7/15/2025 | $423,500 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R00HD108801 | Sex and physiological State dependent molecular characterization of circuits governing parental behavior | 000 | 3 | NIH | 9/4/2025 | $55,774 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | OT2ES038696 | The East Palestine Train Derailment Health Research Program | 000 | 1 | NIH | 9/22/2025 | $1,793,550 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | P20GM156679 | University of Kentucky Diabetes Prevention COBRE | 000 | 1 | NIH | 8/30/2025 | $2,234,231 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R35GM158223 | Molecular Biophysics of Dynamic Bacterial Nanomachines | 000 | 1 | NIH | 9/2/2025 | $359,179 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R00HD108801 | Sex and physiological State dependent molecular characterization of circuits governing parental behavior | 000 | 3 | NIH | 9/4/2025 | $193,226 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AI181567 | Microglial IFN-y production is a key defense system to coordinate both innate and T cell-mediated protective immunity in the brain for preventing reactivation of cerebral Toxoplasma infection | 000 | 1 | NIH | 8/29/2025 | $700,000 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01HL177556 | Targeting NINJ1-mediated Plasma Membrane Rupture to Prevent Thrombosis | 001 | 1 | NIH | 9/15/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AI181567 | Microglial IFN-y production is a key defense system to coordinate both innate and T cell-mediated protective immunity in the brain for preventing reactivation of cerebral Toxoplasma infection | 000 | 1 | NIH | 8/29/2025 | $1,731,364 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01HL177556 | Targeting NINJ1-mediated Plasma Membrane Rupture to Prevent Thrombosis | 000 | 1 | NIH | 9/10/2025 | $538,808 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31AA032200 | Next-Day Effects of Binge Drinking on Inhibitory Control in Laboratory and Naturalistic Settings | 001 | 1 | NIH | 9/17/2025 | $11,055 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31AA032200 | Next-Day Effects of Binge Drinking on Inhibitory Control in Laboratory and Naturalistic Settings | 002 | 1 | NIH | 9/17/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31AA032200 | Next-Day Effects of Binge Drinking on Inhibitory Control in Laboratory and Naturalistic Settings | 000 | 1 | NIH | 9/9/2025 | $38,483 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG095675 | RNA modifications leading to pathophysiological translation of circRNAs in AD | 000 | 1 | NIH | 9/9/2025 | $595,769 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK139147 | Deciphering the Mechanisms by which Long Chain Fatty Acid Oxidation Influences Spatial Microvesicular Steatosis | 000 | 1 | NIH | 9/4/2025 | $2,651,504 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | RM1DA064496 | Kentucky Women's Justice Community Overdose Innovation Network - Phase II | 000 | 1 | NIH | 8/27/2025 | $1,445,488 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01NS138293 | Function of sphingoid bases in brain health and disease | 000 | 1 | NIH | 8/12/2025 | $377,262 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK140148 | Role of Hypothalamic Adgrl1 in Counteracting Hypoglycemia | 000 | 1 | NIH | 6/16/2025 | $538,354 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R25CA302429 | Markey STRONG Scholars Program | 000 | 1 | NIH | 8/4/2025 | $223,823 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | P01AG078116 | Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias | 001 | 4 | NIH | 5/27/2025 | $3,958,139 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | P01AG078116 | Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias | 000 | 3 | NIH | 3/14/2025 | $230,000 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA282254 | Integrative Targeted Therapy for Melanoma | 001 | 2 | NIH | 5/22/2025 | $60,862 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21CA285253 | Novel Strategy to Augmenting Immunotherapy against Melanoma | 001 | 2 | NIH | 5/23/2025 | $21,300 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA282254 | Integrative Targeted Therapy for Melanoma | 000 | 2 | NIH | 3/14/2025 | $547,758 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21CA285253 | Novel Strategy to Augmenting Immunotherapy against Melanoma | 000 | 2 | NIH | 3/14/2025 | $191,693 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | UH3NS134920 | Long-acting aldicarb hydrolase as a medical countermeasure for aldicarb poisoning | 000 | 3 | NIH | 8/28/2025 | $643,949 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F30NS141486 | Fellowship for Annabel McAtee: Elucidating the role of the dura mater in the post-stroke B cell response | 001 | 1 | NIH | 7/31/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F30NS141486 | Fellowship for Annabel McAtee: Elucidating the role of the dura mater in the post-stroke B cell response | 000 | 1 | NIH | 7/31/2025 | $43,138 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K01AG092253 | Feasibility, Acceptability, and Preliminary Efficacy of an HIV Prevention Intervention for Older Black Women | 000 | 1 | NIH | 8/22/2025 | $128,654 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AR084850 | Regulation of Myonuclear Turnover Dynamics in Multinucleated Muscle Cells | 001 | 1 | NIH | 9/2/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AR084850 | Regulation of Myonuclear Turnover Dynamics in Multinucleated Muscle Cells | 000 | 1 | NIH | 8/22/2025 | $554,797 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21HD119324 | SOX9: A Novel Mediator of the Ovulatory Process in the Human Ovary | 000 | 1 | NIH | 8/27/2025 | $419,014 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R33DA061365 | An innovative, trauma-informed approach for reducing overdose risk among women re-entering the community from prison | 000 | 2 | NIH | 7/23/2025 | $1,030,973 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R35GM159612 | Targeting Membrane Environments: The Role of Oleate Hydratase (OhyA) in Lipid-Protein Interactions Across Microbial Communities | 000 | 1 | NIH | 8/6/2025 | $406,652 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | S15OD039798 | Modernization of Sterilization Equipment in the UK Todd Vivarium | 000 | 1 | NIH | 8/13/2025 | $350,000 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01HD116429 | The role of glucocorticoid receptor in the ovary | 000 | 1 | NIH | 7/8/2025 | $665,122 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R13HL182218 | Don S. Fredrickson Lipid Research Conference | 000 | 1 | NIH | 8/15/2025 | $10,000 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R25AG092311 | Kentucky Postbaccalaureate Alzheimer’s Disease Research Education Program (KYPAD) | 000 | 1 | NIH | 8/14/2025 | $418,309 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG070952 | Dynamic GABA and Glutamate Neurotransmission in Alzheimer’s Disease and Aging | 001 | 3 | NIH | 6/13/2025 | $53,050 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG070952 | Dynamic GABA and Glutamate Neurotransmission in Alzheimer’s Disease and Aging | 000 | 3 | NIH | 3/4/2025 | $596,811 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21HD119902 | Elucidating mechanisms underlying the pathogenesis of Hao Fountain Syndrome, a rare disease caused by USP7 variants | 000 | 1 | NIH | 7/23/2025 | $456,892 |
|
